Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€10.30

€10.30

-3.810%
-0.4
-3.810%
-

-

 
20.05.24 / Tradegate WKN: A2QHK8 / Name: Maravai Lifesciences Hldgs Inc / Stock / ? /

Maravai Lifesciences Hldgs Inc Stock

Maravai Lifesciences Hldgs Inc took a tumble today and lost -€0.400 (-3.810%).
Our community identified positive and negative aspects for Maravai Lifesciences Hldgs Inc stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Maravai Lifesciences Hldgs Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.

Pros and Cons of Maravai Lifesciences Hldgs Inc in the next few years

Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-11-11

Analyzing financial statements and ratios offers a comprehensive view into a company’s financial health, and Maravai Lifesciences Hldgs Inc is no exception. At a glance, the company registers some intriguing data points, although the complete picture necessitates a more in-depth analysis.

Delving into the financial metrics reveals a diverse financial picture. Operating with a market capitalization of around $1.1 billion, Maravai Lifesciences' stature in its industry becomes evident. High market capitalization often indicates a strong market presence and suggests investor confidence.

A point to commend in Maravai's financials is its EPS (Earnings per Share) value. The current EPS estimate for the year stands at 1.39, with a trailing EPS at 0.17. These figures, especially the positive trailing EPS, denote profitability, affirming that the company is generating revenue exceeding its expenses.